Gilead Sciences
Gilead Sciences Quality Analysis
Gilead Sciences (GILD) is an average quality business scoring 57/100. While the company generates positive returns, it lacks the exceptional attributes that characterize durable competitive advantages. Investors should demand a meaningful discount to fair value before investing.
Does Gilead Sciences have a strong competitive moat?
Gilead Sciences shows a solid competitive position with solid gross margins of 77.6%. However, returns on capital that fall short of elite levels suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.
Does Gilead Sciences have pricing power in its industry?
Gilead Sciences shows weak pricing power. Margins are below industry norms and may be declining. The business appears to compete primarily on price, leaving it vulnerable to cost increases and competitive pressure on profitability.
How predictable is Gilead Sciences's business?
Gilead Sciences has moderate predictability. Financial results have shown some volatility, with periods of uneven revenue or cash flow performance. While the business generates returns, forecasting its near-term trajectory requires more caution due to this variability.
Is Gilead Sciences financially strong?
Gilead Sciences maintains a solid financial position. Debt levels are manageable, and the company generates sufficient cash to service its obligations. While not a fortress balance sheet, the financial position poses no immediate concerns and provides reasonable flexibility.
How effective is Gilead Sciences's capital allocation strategy?
Gilead Sciences shows solid capital allocation. Returns on capital exceed the cost of capital, and management balances reinvestment with shareholder returns reasonably well. There is room for improvement, but overall capital deployment creates value.
Does Gilead Sciences have high-quality management?
Gilead Sciences's management shows mixed results. Operational efficiency could be improved, and capital deployment decisions have been inconsistent. The team needs to demonstrate clearer focus on shareholder value creation.
Is Gilead Sciences a quality company?
Gilead Sciences is an average quality company with a quality score of 57/100
Predicted probability of operating margin improvement over the next 12 months
- Financial strength is the strongest dimension at 66/100.
- Pricing power is the weakest area at 35/100 and needs attention.
- Average gross margin of 77.6% over 5 years.
- Positive free cash flow in 10 of the last 10 years.
- Debt-to-equity ratio of 1.29x.
What is the fair value of Gilead Sciences stock?
Is Gilead Sciences a good investment at $140?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.